Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q3 2013 · 10-Q
Revenue$253.37K$253.37K−4.1% vs Q3 2012 Net Income-$9.33M-$9.33MN/M vs Q3 2012 EPS Diluted-$0.34-$0.34N/M vs Q3 2012 Gross Profit$139,990+39.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,964,066N/M Free Cash Flowderived-$1,975,341— Margins · derivedGross margin55.3%+17.3 pt vs Q3 2012
Operating margin-3680.5%−2887.1 pt vs Q3 2012
Net margin-3680.5%−2713.2 pt vs Q3 2012
ended Sep 30, 2013 · filed Oct 25, 2013 · 25 d after period end